Sasaki, Hiroko, Ohara, Noriyuki, Minamikawa, Tsutomu, Umeda, Masahiro, Komori, Takahide, Kojima, Nobue, ...
The metastasis of malignant tumors to the oral cavity remains a rare clinical entity.Most metastatic tumors have the propensity for involving the mandible rather than theoral soft tissues. Herein, we...
Morikawa, Akira, Ohara, Noriyuki, Xu, Qin, Nakabayashi, Koji, DeManno, Deborah A., Chwalisz, Kristof, ...
BACKGROUND A recent clinical trial demonstrated that selective progesterone receptor modulator asoprisnil is effective in reducing uterine leiomyoma volume. We investigated the effects of asoprisnil...
Xu, Qin, Ohara, Noriyuki, Liu, Jin, Amano, Mariko, Sitruk-Ware, Regine, Yoshida, Shigeki, ...
Effects of progesterone receptor modulator CDB-2914 on the expression of the extracellular matrix (ECM) components were examined in cultured human uterine leiomyoma and myometrial cells. ECM...
Wang, Jiayin, Ohara, Noriyuki, Wang, Zhuo, Chen, Wei, Morikawa, Akira, Sasaki, Hiroko, ...
BACKGROUND: This study was conducted to evaluate the effects of a novel selective progesterone receptor modulator (SPRM) asoprisnil on the expression of growth factors and their receptors and on...
Xu, Qin, Ohara, Noriyuki, Chen, Wei, Liu, Jin, Sasaki, Hiroko, Morikawa, Akira, ...
BACKGROUND: This study was conducted to evaluate the effects of graded concentrations (10-8, 10-7 and 10-6 M) of progesterone receptor (PR) modulator CDB-2914 on the protein contents of PR, of...
Wang, Jiayin, Ohara, Noriyuki, Wang, Zhuo, Chen, Wei, Morikawa, Akira, Sasaki, Hiroko, ...
BACKGROUND: This study was conducted to evaluate the effects of a novel selective progesterone receptor modulator (SPRM) asoprisnil on the expression of growth factors and their receptors and on...
Xu, Qin, Ohara, Noriyuki, Chen, Wei, Liu, Jin, Sasaki, Hiroko, Morikawa, Akira, ...
BACKGROUND: This study was conducted to evaluate the effects of graded concentrations (10–8, 10–7 and 10–6 M) of progesterone receptor (PR) modulator CDB-2914 on the protein contents of PR, of...
Wang, Jiayin, Ohara, Noriyuki, Wang, Zhuo, Chen, Wei, Morikawa, Akira, Sasaki, Hiroko, ...
BACKGROUND: This study was conducted to evaluate the effects of a novel selective progesterone receptor modulator (SPRM) asoprisnil on the expression of growth factors and their receptors and on...
Xu, Qin, Ohara, Noriyuki, Chen, Wei, Liu, Jin, Sasaki, Hiroko, Morikawa, Akira, ...
BACKGROUND: This study was conducted to evaluate the effects of graded concentrations (10-8, 10-7 and 10-6 M) of progesterone receptor (PR) modulator CDB-2914 on the protein contents of PR, of...
Akayama, Yuki, Takekida, Shigeki, Ohara, Noriyuki, Tateiwa, Hisashi, Chen, Wei, Nakabayashi, Koji, ...
BACKGROUND: The objective of this study was to elucidate gene expression and immunolocalization of heparin-binding epidermal growth factor-like growth factor (HB-EGF) and human epidermal growth...
Wang, Jiayin, Ohara, Noriyuki, Takekida, Shigeki, Xu, Qin, Maruo, Takeshi
BACKGROUND: The objective of this study was to investigate the comparative effects of heparin-binding epidermal growth factor-like growth factor (HB-EGF) on the growth of cultured human leiomyoma...
Wang, Jiayin, Ohara, Noriyuki, Takekida, Shigeki, Xu, Qin, Maruo, Takeshi
BACKGROUND: The objective of this study was to investigate the comparative effects of heparin-binding epidermal growth factor-like growth factor (HB-EGF) on the growth of cultured human leiomyoma...
Akayama, Yuki, Takekida, Shigeki, Ohara, Noriyuki, Tateiwa, Hisashi, Chen, Wei, Nakabayashi, Koji, ...
BACKGROUND: The objective of this study was to elucidate gene expression and immunolocalization of heparinbinding epidermal growth factor-like growth factor (HB-EGF) and human epidermal growth factor...